COVID-19 and risks to the supply and quality of tests, drugs, and vaccines.

Newton PN., Bond KC., 53 signatories from 20 countries None.

DOI

10.1016/s2214-109x(20)30136-4

Type

Journal

The Lancet. Global health

Publication Date

06/2020

Volume

8

Pages

e754 - e755

Addresses

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, and Infectious Diseases Data Observatory, University of Oxford, Oxford OX3 7FZ, UK; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; School of Public Health, Boston University, Boston, MA, USA. Electronic address: paul@tropmedres.ac.

Keywords

53 signatories from 20 countries, Humans, Pneumonia, Viral, Coronavirus Infections, Vaccines, Pharmaceutical Preparations, Diagnostic Tests, Routine, Risk, Pandemics, Global Health

Permalink Original publication